Norditropin® simplexx® 5 mg/1.5ml    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
78Hypopituitarism1

78. Hypopituitarism    [ 462 clinical trials,   346 drugs,   (DrugBank: 45 drugs),   41 drug target genes,   80 drug target pathways]
Searched query = "Hypopituitarism", "Anterior pituitary hypothyroidism", "Syndrome of abnormal secretion of gonadotropin", "Hyposecretion of gonadotropins", "Adrenocorticotropic hormone deficiency", "ACTH deficiency", "Thyroid-stimulating hormone deficiency", "TSH deficiency", "Growth hormone deficiency", "GH deficiency", "GHD", "CGHD", "AGHD", "Prolactin deficiency", "PRL deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 462 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-018586-39-DK
(EUCTR)
01/06/201012/05/2010Diurnal variation of exogenous peptides - Gh Puls/Jurgita IDiurnal variation of exogenous peptides - Gh Puls/Jurgita I Adults with growth hormone disease (AGHD).Trade Name: Norditropin® SimpleXx® 5 mg/1.5ml
Other descriptive name: GROWTH HORMONE
Trade Name: Norditropin® SimpleXx® 5 mg/1.5ml
Other descriptive name: GROWTH HORMONE
Medical Department M (Endocrinology & Diabetes)NULLNot RecruitingFemale: yes
Male: yes
8Denmark